Yiviva
PrivateLast Round
Series A
Feb 21, 2018
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Yiviva operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in February 2018.
Yiviva is a biotechnology company that develops multi-target therapeutics from botanical medicines to treat complex, aging-associated diseases, with a focus on cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yiviva Comparables
Compare Yiviva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BELX Bio-Pharmaceutical (Taiwan) Corporation | 83% | |
| HUTCHMED (China) Limited | 78% | |
| Tvardi | 71% |
For institutional investors. Book with your work email.
Yiviva Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Yiviva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asian Fund for Cancer Research | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 82% MoM, reaching 5.7K.
- Mar 3, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
Yiviva Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Yiviva's valuation, stock price, and market status.
Is Yiviva a public or private company?
Yiviva is a private company.
What is the current stock price of Yiviva?
Yiviva is a private company, so its shares have no public market price. Caplight tracks Yiviva's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yiviva worth (valuation)?
Valuation information for Yiviva is not publicly available.
Can I buy Yiviva stock?
Yiviva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yiviva's last funding round?
Yiviva's most recent funding round was Series A on February 21, 2018.
Who are the main investors in Yiviva?
Key investors in Yiviva include Asian Fund for Cancer Research.
Will Yiviva IPO soon?
No public IPO plans have been announced for Yiviva.
How can I track Yiviva secondary market activity?
Caplight tracks bids, offers, and trades in Yiviva's shares on secondary markets.